Of Mice and Men: Comparative Analysis of Neuro-Inflammatory Mechanisms in Human and Mouse Using Cause-and-Effect Models
暂无分享,去创建一个
[1] D. Sabatini,et al. mTOR Signaling in Growth, Metabolism, and Disease , 2017, Cell.
[2] Alessandro Lombardo,et al. A computational model to predict the immune system activation by citrus-derived vaccine adjuvants , 2016, Bioinform..
[3] A. Caccamo,et al. Pim1 inhibition as a novel therapeutic strategy for Alzheimer’s disease , 2016, Molecular Neurodegeneration.
[4] Martin Hofmann-Apitius,et al. Computable cause-and-effect models of healthy and Alzheimer's disease states and their mechanistic differential analysis , 2015, Alzheimer's & Dementia.
[5] Sterling C. Johnson,et al. Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease. , 2015, JAMA neurology.
[6] Burkhard Becher,et al. Immune attack: the role of inflammation in Alzheimer disease , 2015, Nature Reviews Neuroscience.
[7] R. Sankowski,et al. Rodent models of neuroinflammation for Alzheimer’s disease , 2015, Journal of Neuroinflammation.
[8] O. Garaschuk,et al. Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.
[9] Keizo Takao,et al. Genomic responses in mouse models greatly mimic human inflammatory diseases , 2014, Proceedings of the National Academy of Sciences.
[10] Michael T. Heneka,et al. Innate immune activation in neurodegenerative disease , 2014, Nature Reviews Immunology.
[11] S. Pimplikar. Neuroinflammation in Alzheimer’s Disease: from Pathogenesis to a Therapeutic Target , 2014, Journal of Clinical Immunology.
[12] Allan R. Jones,et al. Transcriptional Landscape of the Prenatal Human Brain , 2014, Nature.
[13] M. Sastre,et al. Modulation of inflammation in transgenic models of Alzheimer’s disease , 2014, Journal of Neuroinflammation.
[14] R. Burke,et al. Rheb GTPase Regulates β-Secretase Levels and Amyloid β Generation* , 2013, The Journal of Biological Chemistry.
[15] M. Hofmann-Apitius,et al. From integrative disease modeling to predictive, preventive, personalized and participatory (P4) medicine , 2013, EPMA Journal.
[16] Xiaoyuan Chen,et al. Interrogating Tumor Metabolism and Tumor Microenvironments Using Molecular Positron Emission Tomography Imaging. Theranostic Approaches to Improve Therapeutics , 2013, Pharmacological Reviews.
[17] Daniel R. Richards,et al. Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013, Proceedings of the National Academy of Sciences.
[18] Shaohui Wang,et al. Tuberous sclerosis protein 2 (TSC2) modulates CCN4 cytoprotection during apoptotic amyloid toxicity in microglia. , 2012, Current neurovascular research.
[19] G. Ferraccioli,et al. Rheumatoid arthritis and Alzheimer's disease: genetic and epigenetic links in inflammatory regulation. , 2012, Discovery medicine.
[20] T. Noda,et al. Loss of Pdk1-Foxo1 Signaling in Myeloid Cells Predisposes to Adipose Tissue Inflammation and Insulin Resistance , 2012, Diabetes.
[21] W. Klein,et al. Intracellular Aβ-oligomers and early inflammation in a model of Alzheimer's disease , 2012, Neurobiology of Aging.
[22] R. Glazer,et al. PPARδ Activation Acts Cooperatively with 3-Phosphoinositide-Dependent Protein Kinase-1 to Enhance Mammary Tumorigenesis , 2011, PloS one.
[23] P. Hart,et al. The anti‐inflammatory effects of interleukin‐4 are not mediated by suppressor of cytokine signalling‐1 (SOCS1) , 2010, Immunology.
[24] D. Howells,et al. Can Animal Models of Disease Reliably Inform Human Studies? , 2010, PLoS medicine.
[25] D. Baker,et al. Inflammation in neurodegenerative diseases , 2010, Immunology.
[26] B. Culver,et al. Suppression of nuclear factor kappa B ameliorates astrogliosis but not amyloid burden in APPswe/PS1dE9 mice , 2009, Neuroscience.
[27] E. Masliah,et al. Role of Tuberin in Neuronal Degeneration , 2008, Neurochemical Research.
[28] J. Strosznajder,et al. Inhibitor of cyclooxygenase-2 protects against amyloid beta peptide-evoked memory impairment in mice. , 2007, Pharmacological reports : PR.
[29] B. Aggarwal,et al. Cyclooxygenase (COX)-2 Inhibitor Celecoxib Abrogates TNF-Induced NF-κB Activation through Inhibition of Activation of IκBα Kinase and Akt in Human Non-Small Cell Lung Carcinoma: Correlation with Suppression of COX-2 Synthesis1 , 2004, The Journal of Immunology.
[30] D. V. van Aalten,et al. PDK1, the master regulator of AGC kinase signal transduction. , 2004, Seminars in cell & developmental biology.
[31] C. Hughes,et al. Of Mice and Not Men: Differences between Mouse and Human Immunology , 2004, The Journal of Immunology.
[32] Y. Song,et al. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin. , 2003, Carcinogenesis.
[33] D. Westaway,et al. Transgenic mouse models of Alzheimer's disease , 2001, Physiology & Behavior.
[34] P. Cohen,et al. The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells , 2000, Current Biology.
[35] B. Hyman,et al. APPSW Transgenic Mice Develop Age‐related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1 , 1997, Journal of neuropathology and experimental neurology.
[36] N. Goldstein. Mice are not men! , 1994, Hawaii medical journal.
[37] L. Kurland,et al. Rheumatoid arthritis and susceptibility to Alzheimer's disease , 1991, The Lancet.
[38] D. Scott,et al. Rheumatold Arthritis and Senile Dementia of the Alzhelmer's Type , 1989 .
[39] P. Treuting,et al. Comprar Comparative Anatomy And Histology. A Mouse And Human Atlas (Online And Print) | Piper M. Treuting | 9780123813619 | Academic Press , 2011 .
[40] Huidong Tang,et al. PPARgamma agonist curcumin reduces the amyloid-beta-stimulated inflammatory responses in primary astrocytes. , 2010, Journal of Alzheimer's disease : JAD.